We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Inivata released data at the American Association for Cancer Research Annual Meeting this week demonstrating the potential of its RaDaR assay for the detection of minimal residual disease (MRD) in cancer and its recurrence. Read More
Abbott subsidiary St. Jude faces a new trial over patent claims by Niazi Licensing concerning a double catheter for the treatment of heart failure after an adverse ruling Monday by the U.S. Court of Appeals for the Federal Circuit. Read More
The German institute concluded that “Stimwave Technologies’ chronic pain management products are innovative medical devices that previously lacked sufficient payment,” the company said. Read More
The test works on self-collected anterior nasal (nares) swabs from people age 14 and up when tested twice over three days with at least 24 hours and no more than 48 hours between tests. Read More
The test analyzes a combination of the number of antibiotics and the number of double dilution steps for each, and how they will work against gram-negative bacteria. Read More
Magnolia Medical Technologies’ Steripath device reduced blood sample contamination rates by 81 percent hospitalwide in a study, according to researchers at a hospital in West Virginia. Read More
Australian diagnostic device developer ResApp Health has entered into a $74 million purchase deal with Pfizer, which will help the drugmaker expand into digital health products. Read More
In the latest in a seemingly endless series of FDA warning letters directed at unapproved COVID-19 products, the agency cited a Michigan-based company about claims it has been making online for its nasal spray. Read More
The rapid test does not differentiate between the SARS-CoV-2 virus, which causes COVID-19, and SARS-CoV, which caused an outbreak of respiratory illness in 2003. Read More